6 results
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous
8-K
EX-10.1
MLYS
Mineralys Therapeutics Inc
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure … to hazardous or toxic substances), and all applicable Laws enforced by the United States Food and Drug Administration (the “FDA”), (including
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
liabilities. We do not maintain insurance for toxic tort claims that may be asserted against us in connection with our third-party manufacturers
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
do not maintain insurance for toxic tort claims that may be asserted against us in connection with our third-party manufacturers’ and suppliers
DRS
rxtxzp6veznjz04xdum9
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next